Sexually Transmitted Infections · 1988 · 18 citations · 9 references
PharmacyInfectious DiseasesPharmacotherapyAntimicrobial PharmacologyAntimicrobial PharmacotherapyInfectious Disease PharmacotherapyAntifungal AgentsAntifungal PharmacotherapyAntifungal ResistanceAntifungal TherapyPessary ManagementSexually Transmitted InfectionsCandida Infection ManagementCandida TherapyProphylactic TreatmentRecurrent Vaginal InfectionsRecurrent Vulvovaginal Candidiasis ManagementVaginal CandidiasisVaginal PessariesVulvovaginal Candidiasis Treatment
In a prospective study, 100 women with recurrent vaginal candidosis were treated with miconazole, using two 100 mg vaginal pessaries a day for one week, then one pessary twice a week for three months followed by one pessary a week for a further three months. Fifty four women elected to continue using one pessary a week for longer than six months. Symptomatic vaginal candidosis did not occur in any patient during regular maintenance treatment. Of the 46 women who discontinued treatment before six months, however, 22 had a recurrence. Maintenance prophylactic treatment with miconazole pessaries appears to be an acceptable and effective method of preventing recurrent episodes of vaginal candidosis.
9
Hepatic Injury Associated With Ketoconazole Therapy
James H. Lewis, Hyman J. Zimmerman, Gordon D. Benson et al. · Gastroenterology · 1984 · 398 citations · Full text
Recurrent Vulvovaginal Candidiasis
Jack D. Sobel · New England Journal of Medicine · 1986 · 219 citations
Annals of Internal Medicine · 1980 · 136 citations
Azole resistance in Candida albicans.
Kalie Smith, David W. Warnock, Claire Kennedy et al. · PubMed · 1986 · 93 citations
Azole resistance in<i>Candida albicans</i>
Kalie Smith, David W. Warnock, Claire Kennedy et al. · Medical Mycology · 1986 · 68 citations